Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of HER-2 Targeted Drugs for Breast Cancer market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of HER-2 Targeted Drugs for Breast Cancermarket, defines the market attractiveness level of HER-2 Targeted Drugs for Breast Cancer market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of HER-2 Targeted Drugs for Breast Cancer industry, describes the types of HER-2 Targeted Drugs for Breast Cancer market, the applications of major players and the market size, and deeply analyzes the current situation of the global HER-2 Targeted Drugs for Breast Cancer market and the development prospects and opportunities of HER-2 Targeted Drugs for Breast Cancer industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global HER-2 Targeted Drugs for Breast Cancer market in Chapter 13.
By Player:
GlaxoSmithKline
CANbridge
Puma Biotechnology
Novartis
Roche
Hetero Drugs
Chugai Pharmaceutical
Pfizer
Hengrui Medicine
Beacon Pharmaceuticals Limited
By Type:
Trastuzumab
Pertuzumab
Lapatinib
Neratinib
Trastuzumab Emtansine
Pyrotinib
Other
By End-User:
Hospital
Clinic
Drug Center
Other
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 HER-2 Targeted Drugs for Breast Cancer Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 HER-2 Targeted Drugs for Breast Cancer Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 HER-2 Targeted Drugs for Breast Cancer Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 HER-2 Targeted Drugs for Breast Cancer Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise HER-2 Targeted Drugs for Breast Cancer Market Analysis and Outlook to 2022
-
7.1 Global HER-2 Targeted Drugs for Breast Cancer Consumption (2017-2022)
-
7.2 United States HER-2 Targeted Drugs for Breast Cancer Consumption (2017-2022)
-
7.3 Europe HER-2 Targeted Drugs for Breast Cancer Consumption (2017-2022)
-
7.4 China HER-2 Targeted Drugs for Breast Cancer Consumption (2017-2022)
-
7.5 Japan HER-2 Targeted Drugs for Breast Cancer Consumption (2017-2022)
-
7.6 India HER-2 Targeted Drugs for Breast Cancer Consumption (2017-2022)
-
7.7 South Korea HER-2 Targeted Drugs for Breast Cancer Consumption (2017-2022)
8 Region and Country-wise HER-2 Targeted Drugs for Breast Cancer Market Analysis and Outlook to 2028
-
8.1 Global HER-2 Targeted Drugs for Breast Cancer Consumption Forecast (2022-2028)
-
8.2 United States HER-2 Targeted Drugs for Breast Cancer Consumption Forecast (2022-2028)
-
8.3 Europe HER-2 Targeted Drugs for Breast Cancer Consumption Forecast (2022-2028)
-
8.4 China HER-2 Targeted Drugs for Breast Cancer Consumption Forecast (2022-2028)
-
8.5 Japan HER-2 Targeted Drugs for Breast Cancer Consumption Forecast (2022-2028)
-
8.6 India HER-2 Targeted Drugs for Breast Cancer Consumption Forecast (2022-2028)
-
8.7 South Korea HER-2 Targeted Drugs for Breast Cancer Consumption Forecast (2022-2028)
9 Global HER-2 Targeted Drugs for Breast Cancer Market Outlook by Types and Applications to 2022
-
9.1 Global HER-2 Targeted Drugs for Breast Cancer Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Trastuzumab Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Pertuzumab Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Lapatinib Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Neratinib Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Trastuzumab Emtansine Consumption and Growth Rate (2017-2022)
-
9.1.6 Global Pyrotinib Consumption and Growth Rate (2017-2022)
-
9.1.7 Global Other Consumption and Growth Rate (2017-2022)
-
9.2 Global HER-2 Targeted Drugs for Breast Cancer Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospital Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Clinic Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Drug Center Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Other Consumption and Growth Rate (2017-2022)
10 Global HER-2 Targeted Drugs for Breast Cancer Market Outlook by Types and Applications to 2028
-
10.1 Global HER-2 Targeted Drugs for Breast Cancer Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Trastuzumab Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Pertuzumab Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Lapatinib Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Neratinib Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global Trastuzumab Emtansine Consumption Forecast and Growth Rate (2022-2028)
-
10.1.6 Global Pyrotinib Consumption Forecast and Growth Rate (2022-2028)
-
10.1.7 Global Other Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global HER-2 Targeted Drugs for Breast Cancer Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Clinic Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Drug Center Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Other Consumption Forecast and Growth Rate (2022-2028)
11 Global HER-2 Targeted Drugs for Breast Cancer Import and Export Analysis (Top 5 Countries)
-
11.1 Global HER-2 Targeted Drugs for Breast Cancer Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global HER-2 Targeted Drugs for Breast Cancer Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 HER-2 Targeted Drugs for Breast Cancer Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global HER-2 Targeted Drugs for Breast Cancer Market Competitive Analysis
-
14.1 GlaxoSmithKline
-
14.1.1 GlaxoSmithKline Company Details
-
14.1.2 GlaxoSmithKline HER-2 Targeted Drugs for Breast Cancer Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 GlaxoSmithKline HER-2 Targeted Drugs for Breast Cancer Product and Service
-
14.2 CANbridge
-
14.2.1 CANbridge Company Details
-
14.2.2 CANbridge HER-2 Targeted Drugs for Breast Cancer Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 CANbridge HER-2 Targeted Drugs for Breast Cancer Product and Service
-
14.3 Puma Biotechnology
-
14.3.1 Puma Biotechnology Company Details
-
14.3.2 Puma Biotechnology HER-2 Targeted Drugs for Breast Cancer Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Puma Biotechnology HER-2 Targeted Drugs for Breast Cancer Product and Service
-
14.4 Novartis
-
14.4.1 Novartis Company Details
-
14.4.2 Novartis HER-2 Targeted Drugs for Breast Cancer Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Novartis HER-2 Targeted Drugs for Breast Cancer Product and Service
-
14.5 Roche
-
14.5.1 Roche Company Details
-
14.5.2 Roche HER-2 Targeted Drugs for Breast Cancer Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Roche HER-2 Targeted Drugs for Breast Cancer Product and Service
-
14.6 Hetero Drugs
-
14.6.1 Hetero Drugs Company Details
-
14.6.2 Hetero Drugs HER-2 Targeted Drugs for Breast Cancer Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Hetero Drugs HER-2 Targeted Drugs for Breast Cancer Product and Service
-
14.7 Chugai Pharmaceutical
-
14.7.1 Chugai Pharmaceutical Company Details
-
14.7.2 Chugai Pharmaceutical HER-2 Targeted Drugs for Breast Cancer Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Chugai Pharmaceutical HER-2 Targeted Drugs for Breast Cancer Product and Service
-
14.8 Pfizer
-
14.8.1 Pfizer Company Details
-
14.8.2 Pfizer HER-2 Targeted Drugs for Breast Cancer Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Pfizer HER-2 Targeted Drugs for Breast Cancer Product and Service
-
14.9 Hengrui Medicine
-
14.9.1 Hengrui Medicine Company Details
-
14.9.2 Hengrui Medicine HER-2 Targeted Drugs for Breast Cancer Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Hengrui Medicine HER-2 Targeted Drugs for Breast Cancer Product and Service
-
14.10 Beacon Pharmaceuticals Limited
-
14.10.1 Beacon Pharmaceuticals Limited Company Details
-
14.10.2 Beacon Pharmaceuticals Limited HER-2 Targeted Drugs for Breast Cancer Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Beacon Pharmaceuticals Limited HER-2 Targeted Drugs for Breast Cancer Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of HER-2 Targeted Drugs for Breast Cancer
-
Figure HER-2 Targeted Drugs for Breast Cancer Picture
-
Table Global HER-2 Targeted Drugs for Breast Cancer Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global HER-2 Targeted Drugs for Breast Cancer Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global HER-2 Targeted Drugs for Breast Cancer Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global HER-2 Targeted Drugs for Breast Cancer Consumption by Country (2017-2022)
-
Figure United States HER-2 Targeted Drugs for Breast Cancer Consumption and Growth Rate (2017-2022)
-
Table Europe HER-2 Targeted Drugs for Breast Cancer Consumption and Growth Rate (2017-2022)
-
Figure China HER-2 Targeted Drugs for Breast Cancer Consumption and Growth Rate (2017-2022)
-
Figure Japan HER-2 Targeted Drugs for Breast Cancer Consumption and Growth Rate (2017-2022)
-
Figure India HER-2 Targeted Drugs for Breast Cancer Consumption and Growth Rate (2017-2022)
-
Figure South Korea HER-2 Targeted Drugs for Breast Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global HER-2 Targeted Drugs for Breast Cancer Consumption Forecast by Country (2022-2028)
-
Figure United States HER-2 Targeted Drugs for Breast Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe HER-2 Targeted Drugs for Breast Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure China HER-2 Targeted Drugs for Breast Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan HER-2 Targeted Drugs for Breast Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure India HER-2 Targeted Drugs for Breast Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea HER-2 Targeted Drugs for Breast Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Trastuzumab Consumption and Growth Rate (2017-2022)
-
Figure Global Pertuzumab Consumption and Growth Rate (2017-2022)
-
Figure Global Lapatinib Consumption and Growth Rate (2017-2022)
-
Figure Global Neratinib Consumption and Growth Rate (2017-2022)
-
Figure Global Trastuzumab Emtansine Consumption and Growth Rate (2017-2022)
-
Figure Global Pyrotinib Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Consumption and Growth Rate (2017-2022)
-
Figure Global Clinic Consumption and Growth Rate (2017-2022)
-
Figure Global Drug Center Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Trastuzumab Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Pertuzumab Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Lapatinib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Neratinib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Trastuzumab Emtansine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Pyrotinib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clinic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Drug Center Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Table Global HER-2 Targeted Drugs for Breast Cancer Import by Region (Top 5 Countries) (2017-2028)
-
Table Global HER-2 Targeted Drugs for Breast Cancer Export by Region (Top 5 Countries) (2017-2028)
-
Table GlaxoSmithKline (Foundation Year, Company Profile and etc.)
-
Table GlaxoSmithKline HER-2 Targeted Drugs for Breast Cancer Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline HER-2 Targeted Drugs for Breast Cancer Product and Service
-
Table CANbridge (Foundation Year, Company Profile and etc.)
-
Table CANbridge HER-2 Targeted Drugs for Breast Cancer Sales, Price, Value and Gross Profit (2017-2022)
-
Table CANbridge HER-2 Targeted Drugs for Breast Cancer Product and Service
-
Table Puma Biotechnology (Foundation Year, Company Profile and etc.)
-
Table Puma Biotechnology HER-2 Targeted Drugs for Breast Cancer Sales, Price, Value and Gross Profit (2017-2022)
-
Table Puma Biotechnology HER-2 Targeted Drugs for Breast Cancer Product and Service
-
Table Novartis (Foundation Year, Company Profile and etc.)
-
Table Novartis HER-2 Targeted Drugs for Breast Cancer Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis HER-2 Targeted Drugs for Breast Cancer Product and Service
-
Table Roche (Foundation Year, Company Profile and etc.)
-
Table Roche HER-2 Targeted Drugs for Breast Cancer Sales, Price, Value and Gross Profit (2017-2022)
-
Table Roche HER-2 Targeted Drugs for Breast Cancer Product and Service
-
Table Hetero Drugs (Foundation Year, Company Profile and etc.)
-
Table Hetero Drugs HER-2 Targeted Drugs for Breast Cancer Sales, Price, Value and Gross Profit (2017-2022)
-
Table Hetero Drugs HER-2 Targeted Drugs for Breast Cancer Product and Service
-
Table Chugai Pharmaceutical (Foundation Year, Company Profile and etc.)
-
Table Chugai Pharmaceutical HER-2 Targeted Drugs for Breast Cancer Sales, Price, Value and Gross Profit (2017-2022)
-
Table Chugai Pharmaceutical HER-2 Targeted Drugs for Breast Cancer Product and Service
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer HER-2 Targeted Drugs for Breast Cancer Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer HER-2 Targeted Drugs for Breast Cancer Product and Service
-
Table Hengrui Medicine (Foundation Year, Company Profile and etc.)
-
Table Hengrui Medicine HER-2 Targeted Drugs for Breast Cancer Sales, Price, Value and Gross Profit (2017-2022)
-
Table Hengrui Medicine HER-2 Targeted Drugs for Breast Cancer Product and Service
-
Table Beacon Pharmaceuticals Limited (Foundation Year, Company Profile and etc.)
-
Table Beacon Pharmaceuticals Limited HER-2 Targeted Drugs for Breast Cancer Sales, Price, Value and Gross Profit (2017-2022)
-
Table Beacon Pharmaceuticals Limited HER-2 Targeted Drugs for Breast Cancer Product and Service
-
